IVORC
  • Register
  • Login

Medical hypothesis, discovery & innovation in optometry

  1. Home
  2. Archives
  3. Vol. 1 No. 2 (2020): Fall 2020
  4. Articles

About the Journal

Editorial Team

Privacy Statement

Contact

Overview of pharmacological treatments for presbyopia

  • Betina Orman
  • Giovanna Benozzi

Medical hypothesis, discovery & innovation in optometry, Vol. 1 No. 2 (2020), 31 October 2020 , Page 67-77
https://doi.org/10.51329/mehdioptometry110 Published 28 February 2021

  • View Article
  • Download
  • Share

Abstract

Background: Presbyopia is the normal progressive waning of accommodation with loss of the visual ability to focus on objects residing at different distances. Presbyopia exacts a cost in quality of life and professional efficiency of many people over 40 years of age. Presbyopia is likely to be 1 of the main pressing visual concerns of the 21st century, given that life expectancy is increasing, resulting in an aging population. This review aimed to address the 3 strategies of the pharmacological treatment for presbyopia.
Methods: A review on PubMed/MEDLINE, Google Scholar, and Clinicaltrials.gov was performed to investigate the English literature on pharmacological treatment for presbyopia from beginning-of-year 2012 to September 30, 2020.
Results: In addition to the treatment of presbyopia with glasses or contact lenses, new surgical strategies have been developed, some of which have been successful. However, during the last decade, a new, promising, non-invasive option for treating presbyopia has emerged: the pharmacological approach. Many researchers have developed 3 different lines of investigation from different assumptions, on a pharmacological basis. The first consisted of producing miosis, to take advantage of a pharmacologically induced pinhole effect, increasing depth-of-focus, and thus improving uncorrected near visual acuity. The second aimed to rehabilitate accommodation binocularly to enable good vision at all distances. Finally, the third approach attempted to rehabilitate lost elasticity in the human crystalline lens.
Conclusions: None of the 3 discussed pharmacological strategies for treating presbyopia, prescribed globally, but patients of restoring accommodation strategy can adhere locally, where they are sold so far as master prescriptions.
Keywords:
  • presbyopia
  • pharmacological presbyopia treatment
  • accommodation
  • eye-drops
  • miosis
  • crystalline lens
  • pinhole
  • uncorrected near visual acuity
  • UNVA
  • ophthalmology
  • vision
  • optometry
  • Full Text PDF
  • Abstract Viewed: 192 times
  • Full Text PDF Downloaded: 0 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Make a Submission
Information
  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

© Copyright 2021-2022 CC BY-NC 4.0. All Rights Reserved.

Medical Hypothesis, Discovery & Innovation in Optometry
ISSN 2693-8391